As stem-cell therapies progress from the R&D stage into clinical testing and ultimately commercialization, the need for reliable and consistent bioreactor technology for the production of these fragile cells has become more pressing.
http://www.biopharminternational.com/biopharm/News/EMD-Millipore-PharmaCell-Collaborate-on-Large-Scal/ArticleStandard/Article/detail/820630?ref=25
http://www.biopharminternational.com/biopharm/News/EMD-Millipore-PharmaCell-Collaborate-on-Large-Scal/ArticleStandard/Article/detail/820630?ref=25
No comments:
Post a Comment